 Staphylococcus aureus
"Staphylococcus aureus" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Potentially pathogenic bacteria found in nasal membranes, skin, hair follicles, and perineum of warm-blooded animals. They may cause a wide range of infections and intoxications.
| Descriptor ID |
D013211
|
| MeSH Number(s) |
B03.300.390.400.800.750.100 B03.353.500.750.750.100 B03.510.100.750.750.100 B03.510.400.790.750.100
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Staphylococcus aureus".
Below are MeSH descriptors whose meaning is more specific than "Staphylococcus aureus".
This graph shows the total number of publications written about "Staphylococcus aureus" by people in this website by year, and whether "Staphylococcus aureus" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1994 | 1 | 0 | 1 | | 1996 | 0 | 1 | 1 | | 1997 | 0 | 2 | 2 | | 1999 | 1 | 2 | 3 | | 2000 | 1 | 1 | 2 | | 2001 | 1 | 2 | 3 | | 2003 | 1 | 1 | 2 | | 2004 | 1 | 2 | 3 | | 2005 | 0 | 1 | 1 | | 2006 | 6 | 0 | 6 | | 2007 | 9 | 2 | 11 | | 2008 | 7 | 4 | 11 | | 2009 | 8 | 4 | 12 | | 2010 | 8 | 3 | 11 | | 2011 | 12 | 5 | 17 | | 2012 | 7 | 5 | 12 | | 2013 | 20 | 6 | 26 | | 2014 | 11 | 3 | 14 | | 2015 | 6 | 3 | 9 | | 2016 | 12 | 3 | 15 | | 2017 | 4 | 3 | 7 | | 2018 | 11 | 5 | 16 | | 2019 | 14 | 4 | 18 | | 2020 | 13 | 3 | 16 | | 2021 | 11 | 5 | 16 | | 2022 | 5 | 11 | 16 | | 2023 | 5 | 9 | 14 | | 2024 | 1 | 0 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Staphylococcus aureus" by people in Profiles.
-
Schilcher K, Severn MM, Jenul C, Avina YC, Keogh RA, Horswill AR. The Staphylococcus aureus CamS lipoprotein is a repressor of toxin production that shapes host-pathogen interaction. PLoS Biol. 2024 Jan; 22(1):e3002451.
-
Deng L, Costa F, Blake KJ, Choi S, Chandrabalan A, Yousuf MS, Shiers S, Dubreuil D, Vega-Mendoza D, Rolland C, Deraison C, Voisin T, Bagood MD, Wesemann L, Frey AM, Palumbo JS, Wainger BJ, Gallo RL, Leyva-Castillo JM, Vergnolle N, Price TJ, Ramachandran R, Horswill AR, Chiu IM. S.?aureus drives itch and scratch-induced skin damage through a V8 protease-PAR1 axis. Cell. 2023 11 22; 186(24):5375-5393.e25.
-
Navanandan N, Bousquet J. Staphylococcus aureus Enterotoxin Sensitization Without Aeroallergen Sensitization: An Important Severe Asthma Phenotype. J Allergy Clin Immunol Pract. 2023 10; 11(10):3062-3063.
-
Holland TL, Cosgrove SE, Doernberg SB, Jenkins TC, Turner NA, Boucher HW, Pavlov O, Titov I, Kosulnykov S, Atanasov B, Poromanski I, Makhviladze M, Anderzhanova A, Stryjewski ME, Assadi Gehr M, Engelhardt M, Hamed K, Ionescu D, Jones M, Saulay M, Smart J, Seifert H, Fowler VG. Ceftobiprole for Treatment of Complicated Staphylococcus aureus Bacteremia. N Engl J Med. 2023 Oct 12; 389(15):1390-1401.
-
Keim KC, Horswill AR. Staphylococcus aureus. Trends Microbiol. 2023 12; 31(12):1300-1301.
-
Simpson EL, Schlievert PM, Yoshida T, Lussier S, Boguniewicz M, Hata T, Fuxench Z, De Benedetto A, Ong PY, Ko J, Calatroni A, Rudman Spergel AK, Plaut M, Quataert SA, Kilgore SH, Peterson L, Gill AL, David G, Mosmann T, Gill SR, Leung DYM, Beck LA. Rapid reduction in Staphylococcus aureus in atopic dermatitis subjects following dupilumab treatment. J Allergy Clin Immunol. 2023 11; 152(5):1179-1195.
-
Haynes AS, Maples H, Parker S. Time for a Change: Considering Vancomycin Alternatives for Pediatric Methicillin-Resistant Staphylococcus aureus Bacteremia. J Pediatric Infect Dis Soc. 2023 May 31; 12(5):308-318.
-
Jenul C, Keim KC, Jens JN, Zeiler MJ, Schilcher K, Schurr MJ, Melander C, Phelan VV, Horswill AR. Pyochelin biotransformation by Staphylococcus aureus shapes bacterial competition with Pseudomonas aeruginosa in polymicrobial infections. Cell Rep. 2023 06 27; 42(6):112540.
-
Frazier JD, Stoudenmire LL, Wagner JL, Thomas GM, Steele GM, Henao-Mart?nez AF, Franco-Paredes C, Chastain DB. Dalbavancin vs standard of care for Staphylococcus aureus bacteraemia in patients unable to receive outpatient parenteral antimicrobial therapy. Int J Antimicrob Agents. 2023 Jul; 62(1):106842.
-
Weig AW, O'Conner PM, Kwiecinski JM, Marciano OM, Nunag A, Gutierrez AT, Melander RJ, Horswill AR, Melander C. A structure activity relationship study of 3,4'-dimethoxyflavone for ArlRS inhibition in Staphylococcus aureus. Org Biomol Chem. 2023 04 26; 21(16):3373-3380.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|